Ocugen receives Nasdaq bid price deficiency notice; has until June 30, 2025 to cure

Ocugen, Inc.

Nasdaq notified Ocugen on Dec 31, 2024, that its stock closed below $1.00 for 30 consecutive business days.
Ocugen has 180 days, until June 30, 2025, to regain compliance by meeting $1.00 closing bid for 10 consecutive days.
If not cured by June 30, 2025, Ocugen may qualify for a second 180-day period if it meets certain conditions.
Ocugen intends to monitor the bid price and consider options but cannot assure compliance will be regained.
The notice does not immediately affect listing or trading on the Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.